By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

The reporting methods of noninferiority randomized clinical trials are often inconsistent, with many publications omitting ...

A significant issue is under enrollment of women in randomized trials, meaning the percentage of women enrolled isn’t in line ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

"The Belt Collector" Mercedes Mone describes what it's like to carry all her groundbreaking titles around on a daily basis.

More than two years after the Food and Drug Administration held a public workshop on measuring overall survival (OS) in ...

Kimberly (Cary) Demirhan, a registered nurse and assistant director of Education Programs at the Association of Cancer Care Centers (ACCC), sat down for an interview with CURE to discuss the need for ...